Latest News

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.

Street Insider Logo

Revance Therapeutics (RVNC) Announces FDA Acceptance of BLA Resubmission for DaxibotulinumtoxinA for Injection for Glabellar Lines)

Bezinga Logo

Revance Receives FDA Acceptance of BLA Resubmission for DaxiboutlinumtoxinA for Glabellar Lines

Seeking Alpha logo

FDA Accepts Revance Application for Its Injection To Treat Frown Lines

Realself Logo

How Beauty Innovations Are Approved Here and Abroad – Plus the Global Game Changers Doctors are Buzzing About

Allure Logo

What’s The Deal With DAXI, The Neuromodulator Everyone’s Talking About

Nashville Post Logo

Nashville Post: 2022 NAIOP award winners announced

NewBeauty Logo

Here’s How Deep Products and In-Office Treatments Really Penetrate the Skin

NewBeauty Logo

A Derm Approved Guide To Which In-Office Treatments to Book By Season

NewBeauty Logo

RHA 2, 3, 4 and Redensity – What to know about Revance’s HA Fillers

NewBeauty Logo

4 Brand New Face Filler Options You Should Know About Right Now

Med Esthetics Magazine logo

RHA Redensity Filler Improves Perioral Rhytids Up To 52 Weeks 

Pharmaceutical Technology Logo

The FDA approves a new dermal filler to reduce the appearance of wrinkles